Health Canada authorizes Pfizer-BioNTech BA.4/BA.5 Omicron vaccine – CTV

    You can use your smart phone to browse stories in the comfort of your hand. Simply browse this site on your smart phone.

    Using an RSS Reader you can access most recent stories and other feeds posted on this network.

    SNetwork Recent Stories

Health Canada authorizes Pfizer-BioNTech BA.4/BA.5 Omicron vaccine – CTV

by tmnationtalk on October 7, 202298 Views

Oct. 7, 2022

OTTAWA – Health Canada says Canadians ages 12 and up can now be given the Pfizer-BioNTech COVID-19 booster vaccine that targets the BA.4 and BA.5 strains of the Omicron variant.
Health Minister Jean-Yves Duclos and Health Canada officials are scheduled to discuss the approval in detail later today.

The authorization says the vaccine can be given three to six months after a second dose of the primary vaccine series, or the most recent booster shot.

It is the second combination vaccine greenlighted by Health Canada’s vaccine review team, but the first that targets the virus strains that are now most common in Canada.

The Moderna combination shot approved five weeks ago targets the original virus and the first Omicron variant, while the Pfizer shot authorized today targets the BA.4 and BA.5 strains.

Read more: https://www.ctvnews.ca/health/coronavirus/health-canada-authorizes-pfizer-s-bivalent-vaccine-that-targets-omicron-strains-ba-4-and-ba-5-1.6100427

Send To Friend Email Print Story

Comments are closed.

NationTalk Partners & Sponsors Learn More

CLOSE
CLOSE